(19)
(11) EP 2 806 887 A1

(12)

(43) Date of publication:
03.12.2014 Bulletin 2014/49

(21) Application number: 13741080.9

(22) Date of filing: 25.01.2013
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
(86) International application number:
PCT/US2013/023093
(87) International publication number:
WO 2013/112801 (01.08.2013 Gazette 2013/31)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 26.01.2012 US 201261591087 P
06.03.2012 US 201213412816

(71) Applicant: IBC Pharmaceuticals, Inc.
Morris Plains, NJ 07950 (US)

(72) Inventors:
  • CHANG, Chien-Hsing
    Morris Plains New Jersey 07950 (US)
  • GOLDENBERG, David M.
    Morris Plains New Jersey 07950 (US)
  • LIU, Donglin
    Morris Plains New Jersey 07950 (US)

(74) Representative: Bohmann, Armin K. 
Bohmann Anwaltssozietät Nymphenburger Straße 1
80335 München
80335 München (DE)

   


(54) TARGETING INTERFERON-LAMBDA WITH ANTIBODIES POTENTLY ENHANCES ANTI-TUMOR AND ANTI-VIRAL ACTIVITIES